Antibodies anti-Shiga toxin 2 B subunit from chicken egg yolk: Isolation, purification and neutralization efficacy

Toxicon

Volumn 58, Issue 4, 2011, Pages 380-388

  Parma, Y R ^a   Chacana, P A ^a   Roge A ^b   Kahl, A ^a   Cangelosi, A ^b   Geoghegan, P ^b   Lucchesi, P M A ^c   Fernandez Miyakawa M E ^a  

^a INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^b Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

^c UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

Author keywords

Antitoxin; Chicken; IgY technology; Neutralization; Shiga toxin; Stx2B

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN Y; POLYCLONAL ANTIBODY; TOXIN ANTIBODY; VEROTOXIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY ISOLATION; ANTIBODY PRODUCTION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; BIOLOGICAL ACTIVITY; CELL PROTECTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG MECHANISM; EGG YOLK; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; SOLID PHASE EXTRACTION; TOXIN ANALYSIS; VERO CELL; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY AFFINITY; CHICKENS; EGG YOLK; IMMUNOGLOBULINS; MICE; MICE, INBRED STRAINS; NEUTRALIZATION TESTS; RABBITS; SHIGA TOXIN 2;

ESCHERICHIA COLI; MUS; ORYCTOLAGUS CUNICULUS;

EID: 80052358549     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2011.07.009     Document Type: Article

References (52)

1. Acheson D.W., Breucker S., Jacewicz M., Lincicome L.L., Donohue-Rolfe A., Kane A.V., Keusch G.T. Expression and purification of Shiga-like toxin II B subunits. Infect. Immun. 1995, 63:301-308.
2. Akita E.M., Nakai S. Immunoglobulins from egg yolk: Isolation and purification. Food Sci. 1992, 57:629-634.
3. Bengtson I.A. Studies on organisms concerned as causative factors in botulism. Hyg. Lab. Bull. 1924, 136:1-97.
4. Bizhanov G., Vyshniauskis G. A comparison of three methods for extracting IgY from the egg yolk of hens immunized with Sendai virus. Vet. Res. Commun. 2000, 24:103-113.
5. Recommendations for diagnosis of Shiga Toxin-Producing Escherichia coli infections by clinical Laboratories. MMWR 2009, 58:1-14. CDC.
6. Donohue-Rolfe A., Kondova I., Mukherjee J., Chios K., Hutto D., Tzipori S. Antibody based protection of gnotobiotic piglets infected with Escherichia coli O157:H7 against systemic complications associated with Shiga toxin 2. Infect. Immun. 1999, 67:3645-3648.
7. Gassmann M., Thömmes P., Weiser T., Hübscher U. Efficient production of chicken egg yolk antibodies against a conserved mammalian protein. FASEB J. 1990, 4:2528-2532.
8. Gentry M.K., Dalrymple J.M. Quantitative microtiter cytotoxicity assay for Shigella toxin. J. Clin. Microbiol. 1980, 12:361-366.
9. Gomez C.M., Biamonte S., Barragan J., Babusci M., Garavano J., Guillen G., Schade R. Production of chicken antibodies against botulinic toxin A. Adv. Agric. Sci. 2006, 10:25-32.
10. Griffin P.M. Escherichia coli O157:H7 and other enterohaemorrhagic Escherichia coli. Infections of the Gastrointestinal Tract N 1995, 739-761. Raven Press, New York. M.J. Blaser, P.D. Smith, J.I. Ravdin, H.B. Greenberg, R.L. Guerrant (Eds.).
11. Hoffman M.A., Menge C., Casey T.A., Laegreid W., Bosworth B.T., Dean-Nystrom E.A. Bovine immune response to Shiga-Toxigenic Escherichia coli O157:H7. Clin. Vaccine Immunol. 2006, 13:1322-1327.
12. Huang J., Motto D., Bundle D., Sadler E. Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice. Blood 2010, 116:3653-3659.
13. Imai Y., Nagai R., Ono Y., Ishikawa T., Nakagami H., Tanikawa T., Kurohane K. Production of secretory immunoglobulin A against Shiga toxin-binding subunits in mice by mucosal immunization. Infect. Immun. 2004, 72:889-895.
14. Imberechts H., Deprez P., Van Driessche E., Pohl P. Chicken egg yolk antibodies against F18 ab fimbriae of Escherichia coli inhibit shedding of F18 positive E. coli by experimentally infected pigs. Vet. Microbiol. 1997, 54:329-341.
15. Jeong K.I., Chapman-Bonofiglio S., Singh P., Lee J., Tzipori S., Sheoran A.S. In vitro and in vivo protective efficacies of antibodies that neutralize the RNA N-glycosidase activity of Shiga toxin 2. BMC Immunol. 2010, 11:16.
16. Johannes L. The epithelial cell cytoskeleton and intracellular trafficking. I. Shiga toxin B-subunit system: retrograde transport, intracellular vectorization, and more. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 283:G1-G7.
17. Kaper J.B., Nataro J.P., Mobley H.L. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2004, 2:123-140.
18. Karmali M.A., Petric M., Lim C., Fleming P.C., Arbus G.S., Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin producing Escherichia coli. J. Infect. Dis. 1985, 151:775-782.
19. Kim Y.J., Lee S.M., Choi G.E., Hwang S.H., Kim H.H., Lee E.Y., Chang C.L. Performance of an enzyme-linked immunosorbent assay for detection of Clonorchis sinensis infestation in high- and low-risk groups. J. Clin. Microbiol. 2010, 48:2365-2367.
20. Kozlov Y.V., Kabishev A.A., Lukyanov E.V., Bayev A.A. The primary structure of the operons coding for Shigella dysenteriae toxin and temperature phage.H30 shiga-like toxin. Gene 1988, 67:213-221.
21. Krüger A., Lucchesi P.M., Parma A.E. Verotoxins in bovine and meat verotoxin-producing Escherichia coli isolates: type, number of variants, and relationship to cytotoxicity. Appl. Environ. Microbiol. 2011, 77:73-79.
22. Krystle L.M., Melton-Celsa A.R., Robinson C.M., O'Brien A.D. Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7. Vaccine 2010, 28:4777-4785.
23. Kweon C.H., Kwon B.J., Woo S.R., Kim J.M., Woo G.H., Son D.H., Hur W., Lee Y.S. Immunoprophylactic effect of chicken egg yolk immunoglobulin (IgY) against porcine epidemic diarrhea virus (PEDV) in piglets. J. Vet. Med. Sci. 2000, 62:961-964.
24. LeClaire R.D., Hunt R.E., Bavari S. Protection against bacterial staphylococcal enterotoxin B by passive vaccination. Infect. Immun. 2002, 70:2278-2281.
25. Lee E.N., Sunwoo H., Menninen K., Sim J.S. Vitro studies of chicken egg yolk antibody (IgY) against Salmonella enteritidis and Salmonella typhimurium. Poult. Sci. 2002, 81:632-641.
26. Ludwig K., Karmali M.A., Sarkim V., Bobrowski C., Petric M., Karch H., Muller- Wiefel D.E. Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome. J. Clin. Microbiol. 2001, 39:2272-2279.
27. Marcato P., Mulvey G., Read R., Vander Helm K., Nation P., Armstrong G. Immunoprophylactic potencial of cloned Shiga Toxin 2B subunit. J. Inf. Dis. 2001, 183:435-443.
28. Marcato P., Griener T., Mulvey G., Armstrong G. Recombinant shiga toxin B-Subunit-Keyhole Limpet Hemocyanin Conjugate Vaccine protects mice from Shigatoxemia. Infect. Immunity 2005, 73:6523-6529.
29. Markus R.A., Frank J., Groshen S., Azen S.P. An alternative approach to the optimal design of an LD50 bioassay. Stat. Med. 1995, 14:841-852.
30. Marquardt R., Jin L.Z., Kim J.W., Fang L., Frohlich A., Baidoo S. Passive protective effect of egg-yolk antibodies against enterotoxigenic Escherichia coli K88+ infection in neonatal and early-weaned piglets. FEMS Immunol. Med. Microbiol. 1999, 23:283-288.
31. Mine Y., Kovacs-Nolan J. Chicken egg yolk antibodies as therapeutics in enteric infectious disease: a review. J. Med. Food 2002, 5:159-169.
32. Motoi Y., Sato K., Hatta H., Morimoto K., Inoue S., Yamada A. Production of rabies neutralizing antibody in hen's eggs using a part of the G protein expressed in Escherichia coli. Vaccine 2005, 23:3026-3032.
33. Nataro J.P., Kaper J.B. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 1998, 11:142-201.
34. Orth D., Grif K., Zimmerhackl L.B., Würzner R. Prevention and treatment of enterohemorrhagic Escherichia coli infections in humans. Expert Rev. Anti-Infect. Ther. 2008, 6:101-108.
35. Parma A.E., Sanz M.E., Blanco J.E., Blanco J., Viñas M.R., Blanco M., Padola N.L., Etcheverría A.I. Virulence genotypes and serotypes of verotoxigenic Escherichia coli isolated from cattle and foods in Argentina. Importance in public health. Europ. J. Epidemiol. E. 2000, 16:757-762.
36. Pauly D., Dorner M., Zhang X., Hlinak A., Dorner B., Schade R. Monitoring of laying capacity, immunoglobulin Y concentration, and antibody titer development in chickens immunized with ricin and botulinum toxins over a two-year period. Poult. Sci. 2009, 88:281-290.
37. Reed L., Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 1938, 27:493-497.
38. Rivas M., Padola N.L., Lucchesi P.M.A., Massana M. Chapter 10: diarrheagenic Escherichia coli in Argentina. Pathogenic Escherichia coli in Latin America 2010, pp. 142-161, Bentham Science Publishers Ltd, Oak Park (IL), Estados Unidos. A.G. Torres (Ed.).
39. Schade R., Henklein P., Hlinak A., de Vente J., Steinbusch H. Specificity of chicken (IgY) versus rabbit (IgG) antibodies raised against cholecystokinin octapeptide (CCK-8). ALTEX 1996, 13(Suppl.):80-85.
40. Schade R., Calzado E.G., Sarmiento R., Chacana P.A., Porankiewicz-Asplund J., Terzolo H.R. Chicken egg yolk antibodies (IgY-technology): a review of progress in production and use in research and human and veterinary medicine. Altern. Lab. Anim. 2005, 33:129-154.
41. Schade R., Chacana P.A. Egg yolk compounds - Livetin fractions. En: Bioactive Egg Compounds 2007, 25-32. Springer, Germany. R. Huopalahti, R. Lopez- Fandiño, M. Antón, R. Schade (Eds.).
42. Shin J.H., Yang M., Nam S.W., Kim J.T., Myung N.H., Bang W.G., Roe I.H. Use of egg yolk-derived immunoglobulin as an alternative to Antibiotic treatment for control of Helicobacter pylori infection. Clin. Diagn. Lab. Immunol. 2002, 9:1061-1066.
43. Smith D.J., King W.F., Godiska R. Passive transfer of immunoglobulin Y antibody to Streptococcus mutans glucan binding protein B can confer protection against experimental dental caries. Infect. Immun. 2001, 69:3135-3142.
44. Spira O., Gafni M., Ben-David C., Gross J., Gordon A. TSH binding proteins in rat and human serum. Acta Endocrinol. (Copenh) 1987, 115:497-506.
45. Sunwoo H., Wang W., Sim J. Detection of Escherichia coli 0157:H7 using chicken immunoglobulin Y. Immunol. Lett. 2006, 106:191-193.
46. Tesh V.L., Burris J.A., Owens J.W. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect. Immun. 1993, 61:3392-3402.
47. Tini M., Jewell U.R., Camenisch G., Chilov D., Gassmann M. Generation and application of chicken egg-yolk antibodies. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2002, 131:569-574.
48. Tzipori S., Sheoran A., Akiyoshi D., Donohue-Rolfe A., Trachtman H. Antibody therapy in the management of Shiga toxin-induced hemolytic uremic syndrome. Clin. Microbiol. Rev. 2004, 17:926-941.
49. Wang Q., Hou X., Cai K., Li T., Liu Y., Tu W., Xiao L., Bao S., Shi J., Gao X., Liu H., Tian R., Wang H. Passive protection of purified yolk immunoglobulin administered against Shiga toxin 1 in mouse models. Can. J. Microbiol. 2010, 56:1003-1010.
50. Yamagami S., Motoki M., Kimura T., Izumi H., Takeda T., Katsuura Y. Efficacy of postinfection treatment with anti-Shiga toxin (Stx) 2 humanized monoclonal antibody TMA-15 in mice lethally challenged with Stx-producing Escherichia coli. J. Infect. Dis. 2001, 184:738-742.
51. Young C.A., Silversides F.G., Jones R.M. Chicken-derived IgY recognizes developing and mature stages of Loma salmonae (Microsporidia) in Pacific salmon, Oncorhynchus spp. Aquaculture 2007, 273:398-404.
52. Zhang W. The use of gene specific-IgY antibodies for drug target discovery. Drug Discov. 2003, 8:364-371.